ANIP
Ticker
ANI Pharmaceuticals, Inc.
ANIP · Healthcare · ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in…ANI Pharmaceuticals, Inc. (ANIP), in the Healthcare sector, has 26 disclosed filings on Paydirt over the trailing twelve months from 10 corporate insiders: 0 purchases and 26 sales. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed Sep 15 and filed Sep 16. The most active filer was Stephen P. Carey with 8 filings.
Add to watchlistFilings, ttm
26
0 buys · 26 sells
Traders, ttm
10
10 insiders
Volume, ttmiDollar value disclosed in the window
$14.3M
estimated for Congress, as filed for insiders
Median delay
2d
execution to disclosure
Last traded
Sep 15
Filed Sep 16
ADViAverage daily dollar volume
$26.1M
market data
Share price · 12M
$71.23 (-25.7%)
Adjusted for splits and dividends.
Volume by month
Buys $0
Sells $54.0M
Estimated for Congress, as filed for insiders · by filing month · past 24 months
Who filed
SCRecent filings
Nikhil LalwaniSALE
PRESIDENT & CEO
$383K5,400 sh × $71.00
Exec Sep 15
Filed Sep 16 · 4:20 PM ET Stephen P. CareySALE SVP & CFO $207K
2,850 sh × $72.80
Exec Aug 31
Filed Sep 1 · 6:18 PM ET Nikhil LalwaniSALE PRESIDENT & CEO $401K
5,400 sh × $74.30
Exec Aug 25
Filed Aug 26 · 6:15 PM ET Ori GutwergSALE SVP, GENERICS $243K
3,162 sh × $77.00
Exec Aug 10
Filed Aug 11 · 8:57 PM ET Stephen P. CareySALE SVP & CFO $232K
2,850 sh × $81.36
Exec Jul 29
Filed Jul 30 · 4:02 PM ET Stephen P. CareySALE SVP & CFO $285K
3,313 sh × $86.00
Exec Jul 2
Filed Jul 6 · 9:40 PM ET Stephen P. CareySALE SVP & CFO $240K
2,850 sh × $84.12
Exec Jun 29
Filed Jun 30 · 5:30 PM ET Thomas HaugheySALE Director $162K
2,000 sh × $80.88
Exec Jun 8
Filed Jun 10 · 5:30 PM ET Stephen P. CareySALE SVP & CFO $265K
3,312 sh × $80.00
Exec Jun 5
Filed Jun 9 · 5:30 PM ET Ori GutwergSALE SVP, GENERICS $220K
2,772 sh × $79.50
Exec May 12
Filed May 13 · 5:30 PM ET Nikhil LalwaniSALE PRESIDENT & CEO $4.3M
55,000 sh × $77.57
Exec May 11
Filed May 13 · 5:30 PM ET Patrick D WalshSALE Director $1.1M
13,973 sh across 2 lots
Exec May 11
Filed May 13 · 5:30 PM ET Christopher MutzSALE HEAD OF RARE DISEASE $227K
3,162 sh × $71.64
Exec Mar 13
Filed Mar 13 · 5:30 PM ET Thomas Andrew RowlandSALE SVP, HEAD - ESTABLISHED BRANDS $357K
4,772 sh × $74.91
Exec Mar 11
Filed Mar 13 · 5:30 PM ET Krista DavisSALE SVP, CHIEF HR OFFICER $488K
6,572 sh across 2 lots
Exec Mar 6
Filed Mar 10 · 5:30 PM ET Christopher MutzSALE HEAD OF RARE DISEASE $425K
5,723 sh across 2 lots
Exec Mar 6
Filed Mar 10 · 5:30 PM ET Stephen P. CareySALE SVP & CFO $552K
7,312 sh across 2 lots
Exec Mar 5
Filed Mar 5 · 5:30 PM ET Ori GutwergSALE SVP, GENERICS $158K
2,060 sh × $76.50
Exec Mar 3
Filed Mar 4 · 5:30 PM ET Patrick D WalshSALE Director $445K
6,000 sh × $74.23
Exec Mar 3
Filed Mar 3 · 5:30 PM ET Krista DavisSALE SVP, CHIEF HR OFFICER $296K
3,814 sh across 2 lots
Exec Feb 19
Filed Feb 23 · 5:30 PM ET Christopher MutzSALE HEAD OF RARE DISEASE $415K
5,323 sh × $78.02
Exec Feb 20
Filed Feb 23 · 5:30 PM ET Christopher MutzSALE HEAD OF RARE DISEASE $538K
7,032 sh × $76.55
Exec Feb 12
Filed Feb 17 · 5:30 PM ET Krista DavisSALE SVP, CHIEF HR OFFICER $134K
1,622 sh × $82.40
Exec Dec 18 2025
Filed Dec 19 2025 · 5:30 PM ET Renee P TannenbaumSALE Director $146K
1,800 sh × $81.15
Exec Dec 5 2025
Filed Dec 9 2025 · 5:30 PM ET Patrick D WalshSALE Director $751K
8,643 sh × $86.88
Exec Nov 13 2025
Filed Nov 17 2025 · 5:30 PM ET